The further observation of an increased NF-κB signaling in cells with downregulated NKILA confirms the NF-κB-targeting activity of lncRNA NKILA as well as its role in cisplatin resistance of ovarian cancer cells. The gene discussed is NFKB1; the disease is ovarian cancer.